These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32758860)

  • 1. An orally available inverse agonist of estrogen-related receptor gamma showed expanded efficacy for the radioiodine therapy of poorly differentiated thyroid cancer.
    Kim J; Hwang H; Yoon H; Lee JE; Oh JM; An H; Ji HD; Lee S; Cha E; Ma MJ; Kim DS; Lee SJ; Kadayat TM; Song J; Lee SW; Jeon JH; Park KG; Lee IK; Jeon YH; Chin J; Cho SJ
    Eur J Med Chem; 2020 Nov; 205():112501. PubMed ID: 32758860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Potent, Selective, and Orally Bioavailable Estrogen-Related Receptor-γ Inverse Agonists To Restore the Sodium Iodide Symporter Function in Anaplastic Thyroid Cancer.
    Kim J; Song J; Ji HD; Yoo EK; Lee JE; Lee SB; Oh JM; Lee S; Hwang JS; Yoon H; Kim DS; Lee SJ; Jeong M; Lee S; Kim KH; Choi HS; Lee SW; Park KG; Lee IK; Kim SH; Hwang H; Jeon YH; Chin J; Cho SJ
    J Med Chem; 2019 Feb; 62(4):1837-1858. PubMed ID: 30657313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Orally Active Inverse Agonist of Estrogen-related Receptor Gamma (ERRγ), DN200434, A Booster of NIS in Anaplastic Thyroid Cancer.
    Singh TD; Song J; Kim J; Chin J; Ji HD; Lee JE; Lee SB; Yoon H; Yu JH; Kim SK; Yoon GS; Hwang H; Lee HW; Oh JM; Lee SW; Lee J; Choi HS; Na SY; Choi WI; Park YJ; Song YS; Kim YA; Lee IK; Cho SJ; Jeon YH
    Clin Cancer Res; 2019 Aug; 25(16):5069-5081. PubMed ID: 31010838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse Agonist of Estrogen-Related Receptor γ Enhances Sodium Iodide Symporter Function Through Mitogen-Activated Protein Kinase Signaling in Anaplastic Thyroid Cancer Cells.
    Singh TD; Jeong SY; Lee SW; Ha JH; Lee IK; Kim SH; Kim J; Cho SJ; Ahn BC; Lee J; Jeon YH
    J Nucl Med; 2015 Nov; 56(11):1690-6. PubMed ID: 26338896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Inverse Agonist of Estrogen-Related Receptor Gamma, GSK5182, Enhances Na
    Singh TD; Lee JE; Son KH; Lee BR; Kim SK; Gulwani D; Sarangthem V; Jeon YH
    Cells; 2023 Feb; 12(3):. PubMed ID: 36766812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel 4-hydroxytamoxifen analogs as estrogen-related receptor gamma inverse agonists.
    Kim J; Chin J; Im CY; Yoo EK; Woo S; Hwang HJ; Cho JH; Seo KA; Song J; Hwang H; Kim KH; Kim ND; Yoon SK; Jeon JH; Yoon SY; Jeon YH; Choi HS; Lee IK; Kim SH; Cho SJ
    Eur J Med Chem; 2016 Sep; 120():338-52. PubMed ID: 27236015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel inverse agonists of estrogen-related receptors ERRγ and ERRβ.
    Yu DD; Huss JM; Li H; Forman BM
    Bioorg Med Chem; 2017 Mar; 25(5):1585-1599. PubMed ID: 28189393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based discovery of pyrazolamides as novel ERRγ inverse agonists.
    Yang SH; Khadka DB; Han J; Na SY; Shin M; Kim DK; Oh BC; Kim EY; Choi HS; Cho WJ
    Eur J Med Chem; 2023 Mar; 250():115174. PubMed ID: 36805944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Selective ERRγ Inverse Agonists.
    Kim J; Im CY; Yoo EK; Ma MJ; Kim SB; Hong E; Chin J; Hwang H; Lee S; Kim ND; Jeon JH; Lee IK; Jeon YH; Choi HS; Kim SH; Cho SJ
    Molecules; 2016 Jan; 21(1):80. PubMed ID: 26771593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-ray crystal structures of the estrogen-related receptor-gamma ligand binding domain in three functional states reveal the molecular basis of small molecule regulation.
    Wang L; Zuercher WJ; Consler TG; Lambert MH; Miller AB; Orband-Miller LA; McKee DD; Willson TM; Nolte RT
    J Biol Chem; 2006 Dec; 281(49):37773-81. PubMed ID: 16990259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research Progress in Estrogen-related Receptor Gamma (ERRγ) Agonists and Inverse Agonists.
    Zheng Y; Du Y; Zhang H; Lv H; Yan Z; Dong N; Li Q; Wang T
    Curr Med Chem; 2024; 31(24):3653-3667. PubMed ID: 37202889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics of the ERRγ ligand-binding domain bound with agonist and inverse agonist.
    Sasidharan S; Radhakrishnan K; Lee JY; Saudagar P; Gosu V; Shin D
    PLoS One; 2023; 18(4):e0283364. PubMed ID: 37023008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity.
    Greschik H; Flaig R; Renaud JP; Moras D
    J Biol Chem; 2004 Aug; 279(32):33639-46. PubMed ID: 15161930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights of a Lead Optimization Study and Biological Evaluation of Novel 4-Hydroxytamoxifen Analogs as Estrogen-Related Receptor γ (ERRγ) Inverse Agonists.
    Kim J; Woo SY; Im CY; Yoo EK; Lee S; Kim HJ; Hwang HJ; Cho JH; Lee WS; Yoon H; Kim S; Kwon OB; Hwang H; Kim KH; Jeon JH; Singh TD; Kim SW; Hwang SY; Choi HS; Lee IK; Kim SH; Jeon YH; Chin J; Cho SJ
    J Med Chem; 2016 Nov; 59(22):10209-10227. PubMed ID: 27805390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a selective inverse agonist for estrogen related receptor α as a potential agent for breast cancer.
    Zhang L; Liu P; Chen H; Li Q; Chen L; Qi H; Shi X; Du Y
    Eur J Pharmacol; 2016 Oct; 789():439-448. PubMed ID: 27498368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Therapy in Thyroid Cancer: State of the Art.
    Valerio L; Pieruzzi L; Giani C; Agate L; Bottici V; Lorusso L; Cappagli V; Puleo L; Matrone A; Viola D; Romei C; Ciampi R; Molinaro E; Elisei R
    Clin Oncol (R Coll Radiol); 2017 May; 29(5):316-324. PubMed ID: 28318881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redifferentiating agents in non-radioiodine avid cancer.
    Seregni E; Vellani C; Castellani MR; Maccauro M; Pallotti F; Scaramellini G; Guzzo M; Greco A
    Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):513-9. PubMed ID: 19910904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of human estrogen-related receptor alpha in complex with a synthetic inverse agonist reveals its novel molecular mechanism.
    Kallen J; Lattmann R; Beerli R; Blechschmidt A; Blommers MJ; Geiser M; Ottl J; Schlaeppi JM; Strauss A; Fournier B
    J Biol Chem; 2007 Aug; 282(32):23231-9. PubMed ID: 17556356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.
    Schmohl KA; Dolp P; Schug C; Knoop K; Klutz K; Schwenk N; Bartenstein P; Nelson PJ; Ogris M; Wagner E; Spitzweg C
    Thyroid; 2017 Dec; 27(12):1534-1543. PubMed ID: 29032724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-related receptor gamma induces cardiac hypertrophy by activating GATA4.
    Kwon DH; Eom GH; Kee HJ; Nam YS; Cho YK; Kim DK; Koo JY; Kim HS; Nam KI; Kim KK; Lee IK; Park SB; Choi HS; Kook H
    J Mol Cell Cardiol; 2013 Dec; 65():88-97. PubMed ID: 24083978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.